Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Diagnostics Centre, |
RCV004566516 | SCV005049563 | likely pathogenic | Dilated cardiomyopathy 1G | 2023-05-09 | no assertion criteria provided | clinical testing | The variant TTN:c.61067del, p.(Pro20356Hisfs*8), which is located in the coding exon 304 of the TTN gene, results from a deletion of a guanine at nucleotide position 61067. The variant causes a frameshift that results in the replace of a proline residue by a hystidine at protein position 20356, followed by a premature translation stop codon after eight amino acids. The variant affects and exon (304/363) that is present in biologically relevant transcripts and it is predicted to cause protein truncation/absent due to non-sense mediated decay in a gene where loss of function is a known mechanism of disease. The change is located in the front third of the A-band of titin. Heterozygous alterations affecting the A-band are associated with cardiomyopathies (PMID: 32815318). The variant is classified as very rare in the overall population (no carriers in gnomAD, v4.0.0). In summary, this variant is classified as Likely Pathogenic. |
Cardiogenetics and Myogenetics Molecular and Cellular Functional Unit, |
RCV004566516 | SCV005374912 | likely pathogenic | Dilated cardiomyopathy 1G | 2024-01-06 | no assertion criteria provided | clinical testing |